Trials / Completed
CompletedNCT00458185
Study Evaluating Etanercept in Patients With Ankylosing Spondylitis
Multicentre, Open-Labeled Study Of Etanercept In The Treatment Of Patients With Ankylosing Spondylitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the efficacy of etanercept for the treatment of Ankylosing Spondylitis (AS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etanercept |
Timeline
- Start date
- 2006-08-01
- Completion
- 2007-04-01
- First posted
- 2007-04-09
- Last updated
- 2008-03-13
Source: ClinicalTrials.gov record NCT00458185. Inclusion in this directory is not an endorsement.